|
시장보고서
상품코드
2054946
DNA 메틸화 시장 : 제품 및 서비스별, 기술별, 샘플 유형별, 워크플로우 단계별, 용도별DNA Methylation Market, By Product and Service, By Technology, By Sample Type, By Workflow Stage, By Application (Clinical Applications, and Research Applications, By End User, By Testing Model, By Geography ) |
||||||
DNA 메틸화 시장은 2026년에 20억 1,000만 달러로 추정되며, 2033년에 51억 6,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 14.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 20억 1,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간 CAGR: | 14.40% | 2033년 시장 규모 예측: | 51억 6,000만 달러 |
전 세계 DNA 메틸화 시장은 분자생물학 및 후생유전학 연구 분야에서 급속히 성장하고 있는 부문으로, 유전자 발현 조절, 질병 발병, 치료적 개입에서 DNA 메틸화가 수행하는 중요한 역할에 대한 인식이 높아짐에 따라 성장세를 보이고 있습니다. DNA 메틸화는 DNA 서열 내의 시토신 염기에 메틸기가 부착되는 기본적인 후성유전적 변형으로, 근본적인 유전 코드를 변경하지 않고 유전자 발현을 조절하는 중요한 메커니즘으로 기능합니다. 이 시장에는 메틸화 어세이 키트, 시퀀싱 플랫폼, 생물정보학 소프트웨어, 연구자 및 임상의가 다양한 생물학적 시료의 메틸화 패턴을 조사할 수 있도록 지원하는 전문 실험실 서비스 등 폭넓은 제품과 서비스가 포함되어 있습니다.
암의 진행, 신경 질환, 심혈관질환, 노화 과정에 있어 DNA 메틸화의 역할에 대한 이해가 깊어짐에 따라, 이 분야에 대한 연구 투자와 상업적 관심이 크게 높아지고 있습니다. 전장 유전체 비설파이트 시퀀싱, 메틸화 특이적 PCR, 어레이 기반 메틸화 분석과 같은 첨단 기술은 그 어느 때보다 높은 정확도와 처리 능력을 바탕으로 메틸화 변화를 검출하고 정량하는 데 혁명을 일으켰습니다. 이 시장의 성장은 맞춤형 의료, 바이오마커 발견, 신약 개발, 임상 진단 분야의 응용 확대에 힘입어 더욱 가속화되고 있으며, DNA 메틸화 분석은 현대 생물학 연구와 정밀 의료 분야에서 필수적인 도구로서의 입지를 확고히 하고 있습니다.
시장 역학
전 세계 DNA 메틸화 시장은 전반적인 견조한 성장세를 뒷받침하는 몇 가지 강력한 촉진요인에 힘입어 성장하고 있으며, 그 주요 요인은 암 연구의 급격한 증가와 질병의 조기 발견 및 예후 판정에서 DNA 메틸화가 중요한 바이오마커로 인식되고 있다는 점입니다. 전 세계 암 유병률의 증가에 더해, 후생유전체학 연구에 대한 정부의 막대한 자금 지원과 민간 투자가 맞물리면서, 고도 메틸화 분석 도구 및 기술에 대한 전례 없는 수요가 발생하고 있습니다. 또한, 맞춤형 의료 및 신약 개발, 특히 제약 산업에서 표적 치료법을 추구하는 과정에서 DNA 메틸화의 활용이 확대됨에 따라 시장 확산이 크게 촉진되고 있습니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 그 중 하나는 고도의 메틸화 분석 장비 및 시약에 따른 높은 비용으로, 이로 인해 예산이 제한된 소규모 연구 기관이나 연구실에서의 활용이 제한될 가능성이 있습니다.
메틸화 데이터 해석의 복잡성과 전문적인 기술적 지식이 필요하다는 점도 또 다른 장벽이 되고 있습니다. 많은 시설에서는 이러한 첨단 기술을 효과적으로 활용하는 데 필요한 생물정보학 인프라와 숙련된 인력이 부족하기 때문입니다. 또한, 서로 다른 메틸화 분석 플랫폼이나 조사 방법 간의 표준화 문제로 인해 결과의 불일치가 발생할 수 있으며, 이는 임상 현장에서의 광범위한 도입을 저해할 가능성이 있습니다. 이러한 제약이 있음에도 불구하고, 시퀀싱 플랫폼과 조사 기법의 지속적인 기술 발전으로 인해 메틸화 연구에 대한 접근성이 높아지고 비용 대비 효과도 개선됨에 따라, 시장에는 큰 기회가 존재하고 있습니다. 메틸화 데이터 분석에 인공지능(AI)과 기계 학습을 통합하는 움직임이 확대되고 있는 것은, 정확도와 효율성을 높이는 데 있어 유망한 방향을 제시하고 있습니다. 또한, 암 분야를 넘어 신경 질환, 심혈관질환, 노화 연구로 응용 범위가 확대되고 있는 것은, 큰 성장 잠재력을 지닌 새로운 시장 부문을 창출하고 있습니다. 한편, 액체 생검 및 비침습적 진단법에 대한 관심이 높아지고 있는 것은 DNA 메틸화를 활용한 임상 적용에 획기적인 기회를 제공하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 DNA 메틸화 시장의 주요 기업 개요을 작성했습니다.
- 본 보고서의 인사이트를 바탕으로, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 DNA 메틸화 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 DNA 메틸화 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 DNA 메틸화 시장 : 제품 및 서비스별, 2021-2033년
제5장 세계의 DNA 메틸화 시장 : 기술별, 2021-2033년
제6장 세계의 DNA 메틸화 시장 : 샘플 유형별, 2021-2033년
제7장 세계의 DNA 메틸화 시장 : 워크플로우 단계별, 2021-2033년
제8장 세계의 DNA 메틸화 시장 : 용도별, 2021-2033년
제9장 세계의 DNA 메틸화 시장 : 최종사용자별, 2021-2033년
제10장 세계의 DNA 메틸화 시장 : 검사 모델별, 2021-2033년
제11장 세계의 DNA 메틸화 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고문헌과 조사 방법
KSM 26.06.18DNA Methylation Market is estimated to be valued at USD 2.01 Bn in 2026 and is expected to reach USD 5.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.01 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.40% | 2033 Value Projection: | USD 5.16 Bn |
The global DNA methylation market represents a rapidly expanding segment within the molecular biology and epigenetics research landscape, driven by the increasing recognition of DNA methylation's critical role in gene regulation, disease development, and therapeutic interventions. DNA methylation, a fundamental epigenetic modification involving the addition of methyl groups to cytosine bases in DNA sequences, serves as a crucial mechanism for controlling gene expression without altering the underlying genetic code. This market encompasses a comprehensive range of products and services including methylation analysis kits, sequencing platforms, bioinformatics software, and specialized laboratory services that enable researchers and clinicians to investigate methylation patterns across various biological samples.
The growing understanding of DNA methylation's involvement in cancer progression, neurological disorders, cardiovascular diseases, and aging processes has significantly amplified research investments and commercial interest in this field. Advanced technologies such as whole-genome bisulfite sequencing, methylation-specific PCR, and array-based methylation analysis have revolutionized the ability to detect and quantify methylation changes with unprecedented accuracy and throughput. The market's expansion is further supported by increasing applications in personalized medicine, biomarker discovery, drug development, and clinical diagnostics, positioning DNA methylation analysis as an indispensable tool in modern biological research and precision healthcare initiatives.
Market Dynamics
The global DNA methylation market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the primary catalyst being the exponential increase in cancer research and the growing recognition of DNA methylation as a critical biomarker for early disease detection and prognosis. The rising prevalence of cancer worldwide, coupled with substantial government funding and private investments in epigenetic research, has created unprecedented demand for advanced methylation analysis tools and technologies. Additionally, the expanding applications of DNA methylation in personalized medicine and drug development, particularly in the pharmaceutical industry's pursuit of targeted therapies, significantly drives market adoption. However, the market faces notable restraints including the high costs associated with advanced methylation analysis equipment and reagents, which can limit accessibility for smaller research institutions and laboratories with constrained budgets.
The complexity of methylation data interpretation and the requirement for specialized technical expertise present additional barriers, as many facilities lack the necessary bioinformatics infrastructure and skilled personnel to effectively utilize these sophisticated technologies. Furthermore, standardization challenges across different methylation analysis platforms and methodologies can create inconsistencies in results, potentially hindering widespread clinical adoption. Despite these constraints, the market presents substantial opportunities through the continuous technological advancements in sequencing platforms and analysis methods, which are making methylation studies more accessible and cost-effective. The growing integration of artificial intelligence and machine learning in methylation data analysis offers promising avenues for enhanced accuracy and efficiency. Moreover, the expanding applications beyond oncology into neurological disorders, cardiovascular diseases, and aging research create new market segments with significant growth potential, while the increasing focus on liquid biopsy and non-invasive diagnostic methods presents revolutionary opportunities for DNA methylation-based clinical applications.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global DNA methylation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Merck KGaA (MilliporeSigma), Zymo Research, New England Biolabs (NEB), PerkinElmer, Abcam, Bio-Rad Laboratories, Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Roche, Active Motif, and Diagenode (a Hologic company)
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global DNA methylation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA methylation market
Market Segmentation
- Product and Service Insights (Revenue, USD Bn, 2021 - 2033)
- Kits and Reagents (bisulfite conversion, enrichment/capture, PCR/qPCR, controls/standards)
- Instruments (NGS platforms, PCR/qPCR systems, microarray scanners, pyrosequencers)
- Software and Services (analysis/visualization tools, cloud pipelines, custom assay design, data interpretation)
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Bisulfite-based sequencing (WGBS, RRBS, targeted bisulfite sequencing)
- Polymerase Chain Reaction (PCR)-based (MSP, qMSP, COBRA, HRM)
- Enrichment-based (MeDIP-seq, MBD-seq, capture-based panels)
- Array-based (Infinium/EPIC-type methylation arrays)
- Targeted detection (pyrosequencing, MassARRAY, digital PCR)
- Long-read and single-molecule (Nanopore direct, SMRT kinetics)
- Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Tissue (FFPE, fresh/frozen)
- Liquid biopsy (plasma/serum cfDNA, whole blood/PBMC)
- Non-blood (saliva/buccal, urine, CSF)
- Germline/reproductive (sperm, oocytes)
- Others
- Workflow Stage Insights (Revenue, USD Bn, 2021 - 2033)
- Sample collection and DNA extraction
- Bisulfite conversion/chemical treatment
- Enrichment/capture
- Amplification and library preparation
- Sequencing/detection
- Bioinformatics analysis and reporting
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Applications
- Oncology Diagnostics & Prognostics
- Non-Invasive Prenatal Testing (NIPT)
- Genetic Disease Testing
- Other Disease Diagnostics (e.g., Neurological, Infectious)
- Research Applications
- Biomarker Discovery
- Developmental Biology
- Drug Discovery & Development
- Others (Animal Research)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Academic and research institutes
- Hospitals and clinical/diagnostic laboratories
- Pharmaceutical and biotechnology companies
- Contract research/central labs and reference labs
- Others (Forensic laboratories)
- Testing Model Insights (Revenue, USD Bn, 2021 - 2033)
- In-house testing (onsite labs)
- Outsourced testing (CROs/reference labs)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Agilent Technologies
- Merck KGaA (MilliporeSigma)
- Zymo Research
- New England Biolabs (NEB)
- PerkinElmer
- Abcam
- Bio-Rad Laboratories
- Pacific Biosciences (PacBio)
- Oxford Nanopore Technologies
- Roche
- Active Motif
- Diagenode (a Hologic company)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global DNA Methylation Market, By Product and Service
- Global DNA Methylation Market, By Technology
- Global DNA Methylation Market, By Sample Type
- Global DNA Methylation Market, By Workflow Stage
- Global DNA Methylation Market, By Application
- Global DNA Methylation Market, By End User
- Global DNA Methylation Market, By Testing Model
- Global DNA Methylation Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global DNA Methylation Market, By Product and Service, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Kits and Reagents (bisulfite conversion, enrichment/capture, PCR/qPCR, controls/standards)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Instruments (NGS platforms, PCR/qPCR systems, microarray scanners, pyrosequencers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software and Services (analysis/visualization tools, cloud pipelines, custom assay design, data interpretation)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global DNA Methylation Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Bisulfite-based sequencing (WGBS, RRBS, targeted bisulfite sequencing)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polymerase Chain Reaction (PCR)-based (MSP, qMSP, COBRA, HRM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Enrichment-based (MeDIP-seq, MBD-seq, capture-based panels)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Array-based (Infinium/EPIC-type methylation arrays)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Targeted detection (pyrosequencing, MassARRAY, digital PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Long-read and single-molecule (Nanopore direct, SMRT kinetics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global DNA Methylation Market, By Sample Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Tissue (FFPE, fresh/frozen)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Liquid biopsy (plasma/serum cfDNA, whole blood/PBMC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-blood (saliva/buccal, urine, CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Germline/reproductive (sperm, oocytes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global DNA Methylation Market, By Workflow Stage, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Sample collection and DNA extraction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bisulfite conversion/chemical treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Enrichment/capture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Amplification and library preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sequencing/detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bioinformatics analysis and reporting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global DNA Methylation Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Clinical Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oncology Diagnostics & Prognostics
- Non-Invasive Prenatal Testing (NIPT)
- Genetic Disease Testing
- Other Disease Diagnostics (e.g., Neurological, Infectious)
- Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biomarker Discovery
- Developmental Biology
- Drug Discovery & Development
- Others (Animal Research)
9. Global DNA Methylation Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Academic and research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals and clinical/diagnostic laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pharmaceutical and biotechnology companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract research/central labs and reference labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Forensic laboratories)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global DNA Methylation Market, By Testing Model, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- In-house testing (onsite labs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Outsourced testing (CROs/reference labs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global DNA Methylation Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zymo Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs (NEB)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacific Biosciences (PacBio)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Active Motif
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Diagenode (a Hologic company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
